Inventor
Vanessa GAUTTIER
Inventor
FR
Overview
Patents· 8 as inventor
Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.
A61Kprimary
A61KPreparations for medical, dental or toiletry purposes25%
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations25%
C07KPeptides25%
C12NMicroorganisms or enzymes13%
G01NInvestigating or analysing materials by determining their chemical or physical properties9%
Y02ATechnologies for adaptation to climate change3%
PatentTitleYear
12,534,533Anti-chemokine like receptor 1 humanized antibodies and their therapeutic applications202612,448,454Humanized anti-CLEC-1A antibodies and antigen-binding fragments thereof202512,331,115Uses of anti-SIRPg antibodies202512,252,546Anti-SIRPa antibodies and their therapeutic applications202512,091,464Method of promoting a t-cell response or treating cancer by administering an antagonist to human c-type lectin-like receptor-1 (CLEC-1)202411,884,723Use of anti-human SIRPa v1 antibodies and method for producing anti-SIRPa v1 antibodies202411,365,257Methods for promoting t cells response by administering an antagonist of human c-type lectin-like receptor 1 (CLEC-1)202211,279,766Anti-SIRPa antibodies and their therapeutic applications2022Career & activity timeline
Assembled from patent assignee/location history and declaration credentials.
2022–2026Patents assigned to OSE IMMUNOTHERAPEUTICS (8)· patent assignee history
2022–2025Patents assigned to INST NAT SANTE RECH MED (3)· patent assignee history
2022–2025Patents assigned to UNIV NANTES (3)· patent assignee history
2022–2026Based in FR· patent location history
Inventor activity
Assignee and location history derived from the patent record.
Assignees
| Assignee | Patents | Span |
|---|---|---|
| OSE IMMUNOTHERAPEUTICS | 8 | 2022–2026 |
| INST NAT SANTE RECH MED | 3 | 2022–2025 |
| UNIV NANTES | 3 | 2022–2025 |
Locations
| Location | Patents | Span |
|---|---|---|
| FR | 8 | 2022–2026 |